Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Microbes: Possible Link Between Modern Lifestyle Transition and the Rise of Metabolic Syndrome Publisher Pubmed



Moossavi S1, 2 ; Bishehsari F3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB, Canada
  3. 3. Department of Internal Medicine, Division of Gastroenterology, Rush University Medical Center, Chicago, IL, United States

Source: Obesity Reviews Published:2019


Abstract

The rapid decrease in infectious diseases globally has coincided with an increase in the prevalence of obesity and other components of metabolic syndrome. Insulin resistance is a common feature of metabolic syndrome and can be influenced by genetic and non-genetic/environmental factors. The emergence of metabolic syndrome epidemics over only a few decades suggests a more prominent role of the latter. Changes in our environment and lifestyle have indeed paralleled the rise in metabolic syndrome. Gastrointestinal tract microbiota, the composition of which plays a significant role in host physiology, including metabolism and energy homeostasis, are distinctly different within the context of metabolic syndrome. Among humans, recent lifestyle-related changes could be linked to changes in diversity and composition of ‘ancient’ microbiota. Given the co-adaptation and co-evolution of microbiota with the immune system over a long period of time, it is plausible that such lifestyle-related microbiota changes could trigger aberrant immune responses, thereby predisposing an individual to a variety of diseases. Here, we review current evidence supporting a role for gut microbiota in the ongoing rise of metabolic syndrome. We conclude that population-level shifts in microbiota can play a mediatory role between lifestyle factors and pathogenesis of insulin resistance and metabolic syndrome. © 2018 World Obesity Federation
Other Related Docs
10. Gut Microbiome and Multiple Sclerosis: New Insights and Perspective, International Immunopharmacology (2020)
12. Lifestyle Alters Gut-Bacteria Function: Linking Immune Response and Host, Best Practice and Research: Clinical Gastroenterology (2017)
14. Role of Gut Microbiome in Polycystic Ovary Syndrome, Journal of Mazandaran University of Medical Sciences (2021)
19. Spondyloarthropathies and Gut Microbiota, Ankylosing Spondylitis - Axial Spondyloarthritis: Cellular# Molecular and Environmental Factors (2021)
20. Non-Alcoholic Fatty Liver Diseases: From Role of Gut Microbiota to Microbial-Based Therapies, European Journal of Clinical Microbiology and Infectious Diseases (2020)
23. The Landscape of Microbiota Research in Iran; a Bibliometric and Network Analysis, Journal of Diabetes and Metabolic Disorders (2020)
32. Precision Medicine in Endocrinology Practice, Precision Medicine in Clinical Practice (2022)
35. The Effects of Medicinal Herbs on Gut Microbiota and Metabolic Factors in Obesity Models: A Systematic Review, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2022)
36. Safety of Probiotic Bacteria, Probiotics# Prebiotics# and Synbiotics: Bioactive Foods in Health Promotion (2016)
42. The Role of Probiotics in Management of Infected Diabetic Foot Ulcers, Journal of Mazandaran University of Medical Sciences (2021)
44. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)